SAM #36C26226Q0845

VA Seeks Sources for Frozen IV Antibiotics for Loma Linda Healthcare System

The Department of Veterans Affairs, Network Contracting Office 22, is conducting market research for a potential multi-year contract to supply frozen intravenous (IV) antibiotics to the VA Loma Linda Healthcare System Pharmacy. - Government Buyer: - Department of Veterans Affairs, Network Contracting Office 22 - VA Loma Linda Healthcare System Pharmacy - Products/Services Requested: - Frozen premix intravenous antibiotics in Galaxy Plastic Containers - Cefazolin 2g/100mL (part number 2G3508), estimated annual quantity: 462 - Cefepime 2g/50mL (part number 2G3579), estimated annual quantity: 48 - Oxacillin 2g/50mL (part number 2G3539), estimated annual quantity: 48 - Cefepime 1g/50mL (part number 2G3578), estimated annual quantity: 23 - Ceftriaxone 1g/50mL (part number 2G3504), estimated annual quantity: 48 - Ceftriaxone 2g/50mL (part number 2G3505), estimated annual quantity: 238 - Unique or Notable Requirements: - All products must be FDA-approved and listed on the VA National Formulary - Medications must be delivered frozen, in premixed form, and in Galaxy Plastic Containers - Minimum remaining shelf life required at delivery - Compliance with the Drug Supply Chain Security Act (DSCSA) - Delivery required within 1-3 business days of order placement - Certificates of analysis or equivalency must be provided upon request - No specific OEMs or manufacturers are named; the opportunity is open to all qualified vendors able to meet the requirements.

Description

THIS REQUEST FOR INFORMATION (RFI) / SOURCES SOUGHT NOTICE IS ISSUED  SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION. SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. SOURCES SOUGHT/RFI DESCRIPTION This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only. The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published.
The Department of Veterans Affairs (VA) is seeking sources capable of providing Frozen Intravenous (IV) Antibiotics to VA Loma Linda Healthcare System Pharmacy Service. STATEMENT OF WORK Background: The Department of Veterans Affairs Loma Linda Healthcare System Pharmacy Service intends to set up a firm fixed price Indefinite Delivery Indefinite Quantity (IDIQ) contract of various frozen intravenous (IV) antibiotics listed below for direct patient care patient care for base plus option four years. These pharmaceuticals are necessary for the treatment of acute or life-threatening conditions.

Period of Performance: Base: 8/20/2026 8/19/2027 Option Year 1 (OY1): 8/20/2027 8/19/2028 Option Year 2 (OY2): 8/20/2028 8/19/2029 Option Year 3 (OY3): 8/20/2029 8/19/2030 Option Year 4 (OY4): 8/20/2030 8/19/2031

Place of Performance: Loma Linda VA Med Center Pharmacy Service 11201 Benton Street Loma Linda, CA 92357

Deliverables: CLIN Description/Part Number* Estimated Qty per year 0001 Cefazolin - 2G3508- Crfazolin in Dextrose injection, USP 2g/100mL (20mg/mL) Single Dose Infusion Bag in 100mL Galaxy Plastic Container, Frozen Premix 462 0002 Cefepime - 2G3579- Cefepime injection 2 gram/50mL in Galaxy Plastic Container, Frozen Premix 48 0003 Oxacillin - 2G3539 - Oxacillin Injection, USP, 2 gram/50mL in Galaxy Plastic Container, Frozen Premix 48 0004 Cefepime - 2G3578 - Cefepime injection 1 gram/50mL in Galaxy Plastic Container, Frozen Premix 23 0005 Ceftriaxone - 2G3504 - Ceftriaxone injection, USP, 1 gram/50mL in Galaxy Plastic Container, Frozen Premix 48 0006 ceftriaxone - 2G3505 - Ceftriaxone injection, USP, 2 gram/50mL in Galaxy Plastic Container, Frozen Premix 238

The quantities cited above charts are estimated quantities per year; quantities are not a contractual statement of precise quantities that the Government will order. The quantities given are estimated only, and no guarantee of their accuracy is either given or implied. The Government will only pay for quantities that are actually ordered and for which the services are fulfilled.

Pricing shall be a firm fixed price.

Requirements: Medication must be FDA-approved and conform to VA National Formulary standards. Product must have a minimum remaining shelf life of [e.g., 6 months] at time of delivery. Delivery must occur within [e.g., 1 3 business days] of order placement. The vendor must comply with VA procurement policy, including Drug Supply Chain Security Act (DSCSA) standards. Products must include a certificate of analysis or equivalency upon request.

Delivery Requirements: Must be delivered to designated units as ordered for medication. Must provide shipment tracking and documentation. Must submit invoices on Tungsten with matching the delivery order Must provide Proof of shipment and delivery confirmation upon request.

The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required. If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions:
(1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements. For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement.
(2) Please review the list of SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A. (3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc. (4) Is your company considered small under the NAICS code identified in this RFI? (5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of SOW? (6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available). (7) If you re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified. (8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6? (9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items? (10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? (11) Please indicate whether your product conforms to the requirements of the Buy American Act? (12) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate. (13) What is estimated life span of your solution? What support/services does that entail? (14) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained. (15) Does your organization offer a leasing solution? Please elaborate. (16) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s). (17) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract. (18) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award. (19) Please provide your SAM.gov Unique Entity ID/Cage Code number. Responses to this notice shall be submitted via email to Hestia.Sim@va.gov. Telephone responses will not be accepted. Responses must be received no later than Monday, June 1, 2026, by 10AM Pacific Local Time.
All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.

View original listing